Maria Kulak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria Kulak has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Esabel Domenico
Faculty of Medicine, Wroclaw Medical University, 50-345 Wroclaw, Poland
1 shared publication - Ewa Anita Jankowska
Institute of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland
1 shared publication - Michał Tkaczyszyn
Institute of Heart Diseases, Wroclaw Medical University , Wroclaw
1 shared publication - Paweł Franczuk
Institute of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland
1 shared publication - Piotr Ponikowski
Wroclaw Medical University
1 shared publication
Latest Publications
- Open Access
- 27 December 2022
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 71
Cardiovascular Complications of Viral Respiratory Infections and COVID-19
Viral respiratory infections (VRI) are the most prevalent type of infectious diseases and constitute one of the most common causes of contact with medical care. Regarding the pathophysiology of the cardiovascular system, VRI can not only exacerbate already existing chronic cardiovascular disease (such as coronary artery disease or heart failure) but also trigger new adverse events or complications (e.g., venous thromboembolism), the latter particularly in subjects with multimorbidity or disease-related immobilization. In the current paper, we provide a narrative review of diverse cardiovascular complications of VRI as well as summarize available data on the pathology of the circulatory system in the course of coronavirus disease 2019 (COVID-19).
- 27 December 2022
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 71
Open AccessCardiovascular Complications of Viral Respiratory Infections and COVID-19
Viral respiratory infections (VRI) are the most prevalent type of infectious diseases and constitute one of the most common causes of contact with medical care. Regarding the pathophysiology of the cardiovascular system, VRI can not only exacerbate already existing chronic cardiovascular disease (such as coronary artery disease or heart failure) but also trigger new adverse events or complications (e.g., venous thromboembolism), the latter particularly in subjects with multimorbidity or disease-related immobilization. In the current paper, we provide a narrative review of diverse cardiovascular complications of VRI as well as summarize available data on the pathology of the circulatory system in the course of coronavirus disease 2019 (COVID-19).